These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
176 related articles for article (PubMed ID: 1343144)
21. Concurrent cyclophosphamide, methotrexate, and 5-fluorouracil chemotherapy and radiotherapy for breast carcinoma: a well tolerated adjuvant regimen. Isaac N; Panzarella T; Lau A; Mayers C; Kirkbride P; Tannock IF; Vallis KA Cancer; 2002 Aug; 95(4):696-703. PubMed ID: 12209711 [TBL] [Abstract][Full Text] [Related]
22. Neoadjuvant chemotherapy for local advanced breast cancer with stage IIIB. Kim R; Osaki A; Tanabe K; Toge T Oncol Rep; 2004 Jun; 11(6):1265-72. PubMed ID: 15138565 [TBL] [Abstract][Full Text] [Related]
23. Adjuvant cyclophosphamide, methotrexate, and fluorouracil in premonopausal patients with node-positive breast cancer: indirect comparison of dose and schedule in DBCG trials 77, 82, and 89. Ejlertsen B; Mouridsen HT; Jensen MB Acta Oncol; 2008; 47(4):662-71. PubMed ID: 18465334 [TBL] [Abstract][Full Text] [Related]
24. Long-term outcome of adjuvant chemotherapy cyclophosphamide, mitoxantrone, and fluorouracil in women with breast cancer. Kumpulainen EJ; Hirvikoski PP; Johansson RT Acta Oncol; 2008; 47(1):120-3. PubMed ID: 18097780 [TBL] [Abstract][Full Text] [Related]
25. [Long-term results of preoperative chemotherapy for operable breast cancer]. Zhang B; Cai Y; Zhang Q Zhonghua Zhong Liu Za Zhi; 1997 Jul; 19(4):277-80. PubMed ID: 11038758 [TBL] [Abstract][Full Text] [Related]
26. Adjuvant treatment for early breast cancer: the Ludwig breast cancer studies. Goldhirsch A; Gelber R NCI Monogr; 1986; (1):55-70. PubMed ID: 3774016 [TBL] [Abstract][Full Text] [Related]
28. Late cardiac effects of adjuvant chemotherapy in breast cancer survivors treated on Southwest Oncology Group protocol s8897. Ganz PA; Hussey MA; Moinpour CM; Unger JM; Hutchins LF; Dakhil SR; Giguere JK; Goodwin JW; Martino S; Albain KS J Clin Oncol; 2008 Mar; 26(8):1223-30. PubMed ID: 18227530 [TBL] [Abstract][Full Text] [Related]
29. Phase III trial evaluating the addition of paclitaxel to doxorubicin followed by cyclophosphamide, methotrexate, and fluorouracil, as adjuvant or primary systemic therapy: European Cooperative Trial in Operable Breast Cancer. Gianni L; Baselga J; Eiermann W; Porta VG; Semiglazov V; Lluch A; Zambetti M; Sabadell D; Raab G; Cussac AL; Bozhok A; Martinez-Agulló A; Greco M; Byakhov M; Lopez JJ; Mansutti M; Valagussa P; Bonadonna G J Clin Oncol; 2009 May; 27(15):2474-81. PubMed ID: 19332727 [TBL] [Abstract][Full Text] [Related]
30. Adjuvant chemotherapy in breast cancer. Del Mastro L; Costantini M; Bianco AR N Engl J Med; 1995 Aug; 333(9):596; author reply 597. PubMed ID: 7623914 [No Abstract] [Full Text] [Related]
31. Breast cancer staging and the "alert": an educational dilemma. Kennedy BJ J Cancer Educ; 1990; 5(2):91-7. PubMed ID: 2206937 [TBL] [Abstract][Full Text] [Related]
32. Role of adjuvant chemotherapy in male breast cancer. Patel HZ; Buzdar AU; Hortobagyi GN Cancer; 1989 Oct; 64(8):1583-5. PubMed ID: 2676137 [TBL] [Abstract][Full Text] [Related]
33. The role of surgery in the combined treatment of locally advanced breast cancer. Canavese G; Catturich A; Battistini G; Caroti C; Pronzato P; Gardin G; Amoroso D; Bertelli G; Conte PF; Tomao S Oncology; 1989; 46(6):353-6. PubMed ID: 2587002 [TBL] [Abstract][Full Text] [Related]
34. CMF adjuvant programs at the Milan Cancer Institute. Bonadonna G; Rossi A; Tancini G; Valagussa P; Veronesi U Recent Results Cancer Res; 1984; 96():66-73. PubMed ID: 6549356 [No Abstract] [Full Text] [Related]
35. Primary (neoadjuvant) chemotherapy and radiotherapy compared with primary radiotherapy alone in stage IIb-IIIa breast cancer. Semiglazov VF; Topuzov EE; Bavli JL; Moiseyenko VM; Ivanova OA; Seleznev IK; Orlov AA; Barash NY; Golubeva OM; Chepic OF Ann Oncol; 1994 Sep; 5(7):591-5. PubMed ID: 7993833 [TBL] [Abstract][Full Text] [Related]
36. A randomized trial of CMF versus CMFVP as adjuvant chemotherapy in women with node-positive stage II breast cancer: a CALGB Study. Wood WC; Weiss RB; Tormey DC; Holland JF; Henry PH; Leone LA; Rafla S; Silver RT; Carey RW; Lesnick GJ World J Surg; 1985 Oct; 9(5):714-8. PubMed ID: 3840627 [No Abstract] [Full Text] [Related]
37. Actual data on efficacy of surgical adjuvant chemotherapy with CMF in breast cancer. Bonadonna G; Rossi A; Valagussa P; Veronesi U Arch Geschwulstforsch; 1978; 48(7):659. PubMed ID: 736746 [No Abstract] [Full Text] [Related]
38. Late effects of adjuvant chemotherapy on cognitive function: a follow-up study in breast cancer patients. Schagen SB; Muller MJ; Boogerd W; Rosenbrand RM; van Rhijn D; Rodenhuis S; van Dam FS Ann Oncol; 2002 Sep; 13(9):1387-97. PubMed ID: 12196364 [TBL] [Abstract][Full Text] [Related]
39. Breast carcinoma in young patients. Ménard S; Casalini P; Cascinelli N; Balsari A Lancet; 2000 Sep; 356(9235):1113. PubMed ID: 11009169 [No Abstract] [Full Text] [Related]
40. A controlled trial of adjuvant chemotherapy with melphalan versus cyclophosphamide, methotrexate, and fluorouracil for breast cancer. Howell A; Rubens RD; Bush H; George WD; Howat JM; Crowther D; Sellwood RA; Hayward JL; Knight RK; Bulbrook RD Recent Results Cancer Res; 1984; 96():74-89. PubMed ID: 6396780 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]